NO20012701D0 - Aryl- og heterosyklylsubstituerte pyrimidinderivater som antikoagulanter - Google Patents

Aryl- og heterosyklylsubstituerte pyrimidinderivater som antikoagulanter

Info

Publication number: NO20012701D0
Authority: NO; Norway
Prior art keywords: anticoagulants; heterocyclyl; aryl; pyrimidine derivatives; substituted pyrimidine
Prior art date: 1998-12-04

Application number

NO20012701A

Other languages

English (en)

Other versions

NO20012701L (no

Inventor

David D Davey

Gary B Phillips

Original Assignee

Berlex Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-04

Filing date

2001-06-01

Publication date

2001-06-01

2001-06-01 Application filed by Berlex Lab filed Critical Berlex Lab

2001-06-01 Publication of NO20012701D0 publication Critical patent/NO20012701D0/no

2001-07-25 Publication of NO20012701L publication Critical patent/NO20012701L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Hematology (AREA)
Oncology (AREA)
Vascular Medicine (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Communicable Diseases (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Separation Of Suspended Particles By Flocculating Agents (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

NO20012701A 1998-12-04 2001-06-01 Aryl- og heterosyklylsubstituerte pyrimidinderivater som antikoagulanter NO20012701L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/205,498 US6127376A (en)	1998-12-04	1998-12-04	Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
PCT/US1999/028537 WO2000033844A1 (en)	1998-12-04	1999-12-03	Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants

Publications (2)

Publication Number	Publication Date
NO20012701D0 true NO20012701D0 (no)	2001-06-01
NO20012701L NO20012701L (no)	2001-07-25

Family

ID=22762435

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20012701A NO20012701L (no)	1998-12-04	2001-06-01	Aryl- og heterosyklylsubstituerte pyrimidinderivater som antikoagulanter

Country Status (26)

Country	Link
US (2)	US6127376A (no)
EP (1)	EP1135131A4 (no)
JP (1)	JP2002531506A (no)
KR (1)	KR20010093799A (no)
CN (1)	CN1329491A (no)
AU (1)	AU760370B2 (no)
BG (1)	BG105557A (no)
BR (1)	BR9915938A (no)
CA (1)	CA2354040A1 (no)
CZ (1)	CZ20011932A3 (no)
EE (1)	EE200100298A (no)
HR (1)	HRP20010499A2 (no)
HU (1)	HUP0104508A3 (no)
IL (2)	IL143347A0 (no)
LT (1)	LT4912B (no)
LV (1)	LV12783B (no)
MX (1)	MXPA01005656A (no)
NO (1)	NO20012701L (no)
NZ (1)	NZ512104A (no)
PL (1)	PL348034A1 (no)
RO (1)	RO120971B1 (no)
RU (1)	RU2001118466A (no)
SI (1)	SI20637A (no)
SK (1)	SK7632001A3 (no)
WO (1)	WO2000033844A1 (no)
ZA (1)	ZA200104235B (no)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0813525T3 (da)	1995-03-10	2004-02-16	Berlex Lab	Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter
US6686364B2 (en)	1997-12-08	2004-02-03	Berlex Laboratories, Inc.	Benzamidine derivatives and their use as anti-coagulants
US6262088B1 (en)	1998-11-19	2001-07-17	Berlex Laboratories, Inc.	Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
US6350761B1 (en)	1999-07-30	2002-02-26	Berlex Laboratories, Inc.	Benzenamine derivatives as anti-coagulants
US7129242B2 (en)	2000-12-06	2006-10-31	Signal Pharmaceuticals, Llc	Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
US7122544B2 (en)	2000-12-06	2006-10-17	Signal Pharmaceuticals, Llc	Anilinopyrimidine derivatives as IKK inhibitors and compositions and methods related thereto
TWI329105B (en) *	2002-02-01	2010-08-21	Rigel Pharmaceuticals Inc	2,4-pyrimidinediamine compounds and their uses
EP1487436A4 (en)	2002-03-08	2009-06-03	Signal Pharm Inc	POLYTHERAPY FOR TREATING, PREVENTING OR MANAGING PROLIFERATIVE DISORDERS AND CANCERS
GB0206215D0 (en)	2002-03-15	2002-05-01	Novartis Ag	Organic compounds
MXPA05001096A (es)	2002-07-29	2005-11-23	Rigel Pharmaceuticals Inc	Metodos para tratamiento o prevencion de enfermedades autoinmunes con compuestos de 2,4-diamino-pirimidina.
WO2004014871A1 (en) *	2002-08-08	2004-02-19	Amgen Inc.	Vanilloid receptor ligands and their use in treatments
AU2003302238A1 (en)	2002-12-03	2004-06-23	Axys Pharmaceuticals, Inc.	2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
AU2004265288A1 (en)	2003-07-30	2005-02-24	Rigel Pharmaceuticals, Inc.	2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
WO2005047268A2 (en) *	2003-11-10	2005-05-26	X-Ceptor Therapeutics, Inc.	Substituted pyrimidine compositions and methods of use
US7557207B2 (en)	2004-11-24	2009-07-07	Rigel Pharmaceuticals, Inc.	Spiro 2,4-pyrimidinediamine compounds and their uses
CN101115761B (zh)	2005-01-19	2012-07-18	里格尔药品股份有限公司	2,4-嘧啶二胺化合物的前药及其应用
WO2007027238A2 (en) *	2005-05-03	2007-03-08	Rigel Pharmaceuticals, Inc.	Jak kinase inhibitors and their uses
BRPI0715428A2 (pt) *	2006-07-21	2013-03-26	Novartis Ag	derivados de pirimidina e seu uso como pesticidas
AU2009244897B2 (en) *	2008-04-16	2014-11-13	Alexion Pharmaceuticals, Inc.	2, 6-diamino- pyrimidin- 5-yl-carboxamides as syk or JAK kinases inhibitors
US8138339B2 (en)	2008-04-16	2012-03-20	Portola Pharmaceuticals, Inc.	Inhibitors of protein kinases
EA029131B1 (ru)	2008-05-21	2018-02-28	Ариад Фармасьютикалз, Инк.	Фосфорсодержащие производные в качестве ингибиторов киназы
US9273077B2 (en)	2008-05-21	2016-03-01	Ariad Pharmaceuticals, Inc.	Phosphorus derivatives as kinase inhibitors
US11351168B1 (en)	2008-06-27	2022-06-07	Celgene Car Llc	2,4-disubstituted pyrimidines useful as kinase inhibitors
US8338439B2 (en)	2008-06-27	2012-12-25	Celgene Avilomics Research, Inc.	2,4-disubstituted pyrimidines useful as kinase inhibitors
RU2536584C2 (ru) *	2008-06-27	2014-12-27	Авила Терапьютикс, Инк.	Гетероарильные соединения и их применение
US8932842B2 (en)	2009-02-11	2015-01-13	Northwestern University	Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition
US8278084B2 (en)	2009-02-11	2012-10-02	Northwestern University	Aminopyridine dimer compounds, compositions and related methods for neuronal nitric oxide synthase inhibition
EP2440559B1 (en)	2009-05-05	2018-01-10	Dana-Farber Cancer Institute, Inc.	Egfr inhibitors and methods of treating disorders
SG187796A1 (en)	2010-08-10	2013-03-28	Celgene Avilomics Res Inc	Besylate salt of a btk inhibitor
WO2012061303A1 (en)	2010-11-01	2012-05-10	Avila Therapeutics, Inc.	Heteroaryl compounds and uses thereof
WO2012061299A1 (en)	2010-11-01	2012-05-10	Avila Therapeutics, Inc.	Heterocyclic compounds and uses thereof
WO2012064706A1 (en)	2010-11-10	2012-05-18	Avila Therapeutics, Inc.	Mutant-selective egfr inhibitors and uses thereof
EA201391626A1 (ru)	2011-05-04	2014-03-31	Ариад Фармасьютикалз, Инк.	Соединения для ингибирования клеточной пролиферации в egfr-стимулированных типах рака
TW201325593A (zh)	2011-10-28	2013-07-01	Celgene Avilomics Res Inc	治療布魯頓（ｂｒｕｔｏｎ’ｓ）酪胺酸激酶疾病或病症之方法
JP6039683B2 (ja)	2011-11-23	2016-12-07	ポートラファーマシューティカルズ，インコーポレイテッド	ピラジンキナーゼ阻害剤
PT2825042T (pt)	2012-03-15	2018-11-16	Celgene Car Llc	Sais de um inibidor de cinases do recetor do fator de crescimento epidérmico
US9056839B2 (en)	2012-03-15	2015-06-16	Celgene Avilomics Research, Inc.	Solid forms of an epidermal growth factor receptor kinase inhibitor
JP6469567B2 (ja)	2012-05-05	2019-02-13	アリアド・ファーマシューティカルズ・インコーポレイテッド	Ｅｇｆｒ発動性がんの細胞増殖阻害用化合物
EP2935226A4 (en)	2012-12-21	2016-11-02	Celgene Avilomics Res Inc	HETEROARYL COMPOUNDS AND USES THEREOF
JP2016509012A (ja)	2013-02-08	2016-03-24	セルジーンアビロミクスリサーチ，インコーポレイテッド	Ｅｒｋ阻害剤およびそれらの使用
US9611283B1 (en)	2013-04-10	2017-04-04	Ariad Pharmaceuticals, Inc.	Methods for inhibiting cell proliferation in ALK-driven cancers
US9492471B2 (en)	2013-08-27	2016-11-15	Celgene Avilomics Research, Inc.	Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase
US9415049B2 (en)	2013-12-20	2016-08-16	Celgene Avilomics Research, Inc.	Heteroaryl compounds and uses thereof
WO2016025561A1 (en)	2014-08-13	2016-02-18	Celgene Avilomics Research, Inc.	Forms and compositions of an erk inhibitor
CN109897005B (zh) *	2019-04-12	2022-07-22	湖南省农业生物技术研究所	含取代苯氧基的苯基嘧啶类似物及其制备方法和应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB824908A (en) *	1958-06-03	1959-12-09	May & Baker Ltd	Improvements in or relating to triazine derivatives
JPS5922697B2 (ja) *	1976-01-13	1984-05-28	エーザイ株式会社	ビス−（メタ−アミジノフエノキシ）−化合物
US5451700A (en) *	1991-06-11	1995-09-19	Ciba-Geigy Corporation	Amidino compounds, their manufacture and methods of treatment
EP0518818A3 (en) *	1991-06-11	1993-04-28	Ciba-Geigy Ag	Arylethers, their manufacture and use as medicament
ZA928276B (en) *	1991-10-31	1993-05-06	Daiichi Seiyaku Co	Aromatic amidine derivates and salts thereof.
WO1993015756A1 (en) *	1992-02-14	1993-08-19	Corvas International, Inc.	Inhibitors of thrombosis
DE4213919A1 (de) *	1992-04-28	1993-11-04	Thomae Gmbh Dr K	Cyclische iminoderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
IL106324A (en) *	1992-07-17	1998-09-24	Shell Int Research	Transformed pyrimidine compounds, their preparation and use as pesticides
AU675981B2 (en) *	1992-12-02	1997-02-27	Bristol-Myers Squibb Company	Guanidinyl-substituted heterocyclic thrombin inhibitors
DE69324041D1 (de) *	1992-12-15	1999-04-22	Corvas Int Inc	NEUE INHIBITOREN VON FAKTOR Xa
US5332822A (en) *	1992-12-24	1994-07-26	Bristol-Myers Squibb Company	Heteroaromatic and thioheteroaromatic substituted sulfonamide thrombin inhibitors
EP0684830B1 (en) *	1993-02-12	1999-06-16	Corvas International, Inc.	Inhibitors of thrombosis
US5633381A (en) *	1994-07-05	1997-05-27	Berlex Laboratories, Inc.	(Z,Z), (Z,E) and (E,Z) isomers of substituted bis(phenylmethylene)cycloketones
IL115420A0 (en) *	1994-09-26	1995-12-31	Zeneca Ltd	Aminoheterocyclic derivatives
US5691364A (en) *	1995-03-10	1997-11-25	Berlex Laboratories, Inc.	Benzamidine derivatives and their use as anti-coagulants
DK0813525T3 (da) *	1995-03-10	2004-02-16	Berlex Lab	Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter
US5612363A (en) *	1995-06-02	1997-03-18	Berlex Laboratories, Inc.	N,N-di(aryl) cyclic urea derivatives as anti-coagulants
US5849759A (en) *	1995-12-08	1998-12-15	Berlex Laboratories, Inc.	Naphthyl-substituted benzimidazole derivatives as anti-coagulants
US5994375A (en)	1996-02-12	1999-11-30	Berlex Laboratories, Inc.	Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants
US5753635A (en) *	1996-08-16	1998-05-19	Berlex Laboratories, Inc.	Purine derivatives and their use as anti-coagulants
US5693641A (en) *	1996-08-16	1997-12-02	Berlex Laboratories Inc.	Bicyclic pyrimidine derivatives and their use as anti-coagulants
US6008234A (en)	1996-09-12	1999-12-28	Berlex Laboratories, Inc.	Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
ES2188979T3 (es) *	1996-09-12	2003-07-01	Schering Ag	Derivados de benzamidina sustituidos con derivados de aminoacidos ciclicos e hidroxiacidos ciclicos, y su uso como anti-coagulantes.
US6004985A (en) *	1996-10-09	1999-12-21	Berlex Laboratories, Inc.	Thio acid derived monocylic N-heterocyclics as anticoagulants
EP0993448A1 (en) *	1997-06-19	2000-04-19	The Du Pont Merck Pharmaceutical Company	(AMIDINO)6-MEMBERED AROMATICS AS FACTOR Xa INHIBITORS
CN1143855C (zh)	1997-12-19	2004-03-31	舍林公开股份有限公司	作为抗凝剂的邻氨基苯甲酰胺衍生物

1998
- 1998-12-04 US US09/205,498 patent/US6127376A/en not_active Expired - Fee Related
1999
- 1999-12-03 SI SI9920090A patent/SI20637A/sl not_active IP Right Cessation
- 1999-12-03 PL PL99348034A patent/PL348034A1/xx not_active Application Discontinuation
- 1999-12-03 MX MXPA01005656A patent/MXPA01005656A/es not_active IP Right Cessation
- 1999-12-03 HU HU0104508A patent/HUP0104508A3/hu unknown
- 1999-12-03 HR HR20010499A patent/HRP20010499A2/hr not_active Application Discontinuation
- 1999-12-03 NZ NZ512104A patent/NZ512104A/en unknown
- 1999-12-03 EE EEP200100298A patent/EE200100298A/xx unknown
- 1999-12-03 RU RU2001118466/14A patent/RU2001118466A/ru not_active Application Discontinuation
- 1999-12-03 JP JP2000586336A patent/JP2002531506A/ja active Pending
- 1999-12-03 WO PCT/US1999/028537 patent/WO2000033844A1/en not_active Ceased
- 1999-12-03 CN CN99814024A patent/CN1329491A/zh active Pending
- 1999-12-03 AU AU31075/00A patent/AU760370B2/en not_active Ceased
- 1999-12-03 RO ROA200100606A patent/RO120971B1/ro unknown
- 1999-12-03 CZ CZ20011932A patent/CZ20011932A3/cs unknown
- 1999-12-03 BR BR9915938-4A patent/BR9915938A/pt not_active IP Right Cessation
- 1999-12-03 IL IL14334799A patent/IL143347A0/xx active IP Right Grant
- 1999-12-03 SK SK763-2001A patent/SK7632001A3/sk unknown
- 1999-12-03 KR KR1020017006934A patent/KR20010093799A/ko not_active Withdrawn
- 1999-12-03 EP EP99965087A patent/EP1135131A4/en not_active Withdrawn
- 1999-12-03 CA CA002354040A patent/CA2354040A1/en not_active Abandoned
2000
- 2000-03-30 US US09/539,812 patent/US6372751B1/en not_active Expired - Fee Related
2001
- 2001-05-23 ZA ZA200104235A patent/ZA200104235B/en unknown
- 2001-05-24 IL IL143347A patent/IL143347A/en not_active IP Right Cessation
- 2001-06-01 BG BG105557A patent/BG105557A/xx unknown
- 2001-06-01 NO NO20012701A patent/NO20012701L/no not_active Application Discontinuation
- 2001-06-12 LT LT2001061A patent/LT4912B/lt not_active IP Right Cessation
- 2001-07-04 LV LVP-01-100A patent/LV12783B/xx unknown

Also Published As

Publication number	Publication date
BR9915938A (pt)	2001-08-21
KR20010093799A (ko)	2001-10-29
LV12783A (en)	2002-01-20
IL143347A (en)	2006-12-10
EP1135131A1 (en)	2001-09-26
EE200100298A (et)	2002-12-16
SK7632001A3 (en)	2001-12-03
MXPA01005656A (es)	2002-04-24
RU2001118466A (ru)	2003-04-20
HUP0104508A3 (en)	2002-07-29
CN1329491A (zh)	2002-01-02
CZ20011932A3 (cs)	2001-10-17
HUP0104508A2 (hu)	2002-05-29
ZA200104235B (en)	2002-08-23
IL143347A0 (en)	2002-04-21
EP1135131A4 (en)	2002-01-02
US6127376A (en)	2000-10-03
PL348034A1 (en)	2002-05-06
AU760370B2 (en)	2003-05-15
LV12783B (en)	2002-10-20
LT4912B (lt)	2002-04-25
BG105557A (en)	2001-12-29
SI20637A (sl)	2002-02-28
CA2354040A1 (en)	2000-06-15
JP2002531506A (ja)	2002-09-24
WO2000033844A1 (en)	2000-06-15
LT2001061A (en)	2001-12-27
RO120971B1 (ro)	2006-10-30
US6372751B1 (en)	2002-04-16
NZ512104A (en)	2003-10-31
NO20012701L (no)	2001-07-25
HRP20010499A2 (en)	2003-04-30
AU3107500A (en)	2000-06-26

Publication	Publication Date	Title
NO20012701D0 (no)	2001-06-01	Aryl- og heterosyklylsubstituerte pyrimidinderivater som antikoagulanter
ATE372988T1 (de)	2007-09-15	Pyrimidin-derivate
HUS1500055I1 (hu)	2016-03-29	HIV-gátló pirimidinszármazékok
DK2253620T3 (da)	2014-03-31	Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer
NO20021239L (no)	2002-03-13	Pteridinoner som kinase-inhibitorer
DK1140840T3 (da)	2006-07-31	omega-carboxyaryl-substituerede diphenylurinstoffer som raf-kinase-inhibitorer
NO20014642D0 (no)	2001-09-25	Aminopyrimidiner som sorbitol-dehydrogenase-inhibitorer
DE60026861D1 (de)	2006-05-11	Purin-derivate
DK1220863T3 (da)	2003-08-11	Purinderivater
IS6196A (is)	2001-12-11	Púrín afleiður
NO20022557D0 (no)	2002-05-29	2,4-diaminopyrimidinforbindelser nyttige som immunosuppreserende midler
NO20016201D0 (no)	2001-12-18	Tienopyrimidiner som fosfodiesteraseinhibitorer
DK1165547T3 (da)	2003-12-22	Substituerede benzoylpyrazoler som herbicider
PT1165495E (pt)	2005-08-31	Derivados de resorcinol
EE200200050A (et)	2003-04-15	Benseenamiini derivaadid antikoagulantidena
DE60012062D1 (de)	2004-08-19	Fluorierte Triazinderivate
DK1347974T3 (da)	2005-03-14	Aminotriazolopyridinderivater som adenosinreceptorligander
DE50102328D1 (de)	2004-06-24	Feuchttücher (i)
DE59910200D1 (de)	2004-09-16	Kühlbares Bauteil
DK1115708T3 (da)	2004-08-02	Aminoalkyl-3,4-dihydriquinolinderivater som NO-synthaseinhibitorer
DK1183236T3 (da)	2004-02-23	Cinnamoylaminoalkylsubstituerede benzensulfonamidderivater
DK1380585T3 (da)	2005-03-07	Pyrazolopyridinon som mellemprodukt
NO20020592D0 (no)	2002-02-06	Fluorenderivater som integrininhibitorer
DK1210333T3 (da)	2005-03-21	p-Tolylsubstituerede heterocycliske forbindelser som herbicider
DK1296981T3 (da)	2005-07-25	Substituerede pyrrolopyridinonderivater som phosphodiesteraseinhibitorer

Legal Events

Date	Code	Title	Description
2005-10-17	FC2A	Withdrawal, rejection or dismissal of laid open patent application